Literature DB >> 1699127

Expression and characterization of the cystic fibrosis transmembrane conductance regulator.

R J Gregory1, S H Cheng, D P Rich, J Marshall, S Paul, K Hehir, L Ostedgaard, K W Klinger, M J Welsh, A E Smith.   

Abstract

Cystic fibrosis (CF) is a common lethal genetic disease that manifests itself in airway and other epithelial cells as defective chloride ion absorption and secretion, resulting at least in part from a defect in a cyclic AMP-regulated, outwardly-rectifying Cl- channel in the apical surface. The gene responsible for CF has been identified and predicted to encode a membrane protein termed the CF transmembrane conductance regulator (CFTR). Identification of a cryptic bacterial promoter within the CFTR coding sequence led us to construct a complementary DNA in a low-copy-number plasmid, thereby avoiding the deleterious effects of CFTR expression on Escherischia coli. We have used this cDNA to express CFTR in vitro and in vivo. Here we demonstrate that CFTR is a membrane-associated glycoprotein that can be phosporylated in vitro by cAMP-dependent protein kinase. Polyclonal and monoclonal antibodies directed against distinct domains of the protein immunoprecipitated recombinant CFTR as well as the endogenous CFTR in nonrecombinant T84 cells. Partial proteolysis fingerprinting showed that the recombinant and non-recombinant proteins are indistinguishable. These data, which establish several characteristics of the protein responsible for CF, will now enable CFTR function to be studied and will provide a basis for diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699127     DOI: 10.1038/347382a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  96 in total

1.  Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10-CFTR2.

Authors:  L J MacVinish; D R Gill; S C Hyde; K A Mofford; M J Evans; C F Higgins; W H Colledge; L Huang; F Sorgi; R Ratcliff; A W Cuthbert
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

2.  Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.

Authors:  R Ratcliff; M J Evans; J Doran; B J Wainwright; R Williamson; W H Colledge
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

Review 3.  The biochemical defect in cystic fibrosis.

Authors:  A W Cuthbert
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

4.  Overexpression of the erythrocyte plasma membrane Ca2+ pump in COS-1 cells.

Authors:  H P Adamo; A K Verma; M A Sanders; R Heim; J L Salisbury; E D Wieben; J T Penniston
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

5.  Genetics and lung disease.

Authors:  J Hopkin
Journal:  BMJ       Date:  1991-05-25

Review 6.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

Review 7.  Cystic fibrosis: an inherited disease affecting mucin-producing organs.

Authors:  Camille Ehre; Caroline Ridley; David J Thornton
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

Review 8.  Outwardly rectifying chloride channels and CF: a divorce and remarriage.

Authors:  W B Guggino
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

9.  A novel mutation in exon 3 of the CFTR gene.

Authors:  H Guillermit; M Jéhanne; I Quéré; M P Audrézet; B Mercier; C Férec
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

10.  Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula.

Authors:  K J Demmers; D Carter; S Fan; P Mao; N J Maqbool; B J McLeod; R Bartolo; A G Butt
Journal:  J Comp Physiol B       Date:  2009-12-12       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.